Gary Kobinger
Gary Kobinger University of Montreal University of Pennsylvania | |
---|---|
Known for | Development of Ebola vaccine and treatment |
Scientific career | |
Fields | |
Institutions | Galveston National Laboratory |
Doctoral advisor | Éric A. Cohen |
Other academic advisors | James Wilson |
Gary P. Kobinger
Biography
Kobinger was born in
Kobinger and his colleague
The NML had been trying to get the rVSV-ZEBOV Ebola vaccine into
After initially being rejected by the
In 2016, Kobinger left the NLM to move back to Quebec to hold the role of Director at the Centre de Recherche en Infectologie (Infectious Diseases Research Center) at Université Laval, where he was also a professor in the Department of Infectious Diseases, Microbiology, and Immunology.[1] As director, his goal was to develop a research framework that can respond rapidly to emerging and re-emerging pathogens. During this time, he was also an assistant professor in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania and an associate professor in the Department of Medical Microbiology at the University of Manitoba.[1]
Kobinger left Canada to become the director of the Galveston National Laboratory at the University of Texas Medical Branch in September 2021, as the result of an international search to fill the position.[1] His switch from a level 3 containment facility at Laval to a level 4 laboratory with “8 times the Canadian capacity in just one facility” allows him to continue his work unrestricted.[6] Facing financial restrictions back at home, amplified by the COVID-19 pandemic, this new role will allow him to pursue his research with far fewer barriers.[7] One of his current goals is to develop a universal coronavirus vaccine in the next handful of years.[6]
Other activities
- Coalition for Epidemic Preparedness Innovations (CEPI), Member of the Scientific Advisory Committee (since 2023)[8]
Awards and Committees
- 2008-2014: WHO co-chair of the Emerging and Dangerous Pathogens Laboratory Global Network for Outbreak Response and Readiness[1]
- 2014: Gully Award[9]
- 2015: Scientist of the Year Award (ICI Radio-Canada)[9]
- 2015: Faculty Teaching Award (University of Manitoba)[9]
- 2016: Meritorious Service Cross (civil division) of the Governor General of Canada[1]
- 2017: Ernest C. Manning Principal Award[1]
- 2018: Governor General’s Innovation Award[2]
- 2020: WHO Strategic and Technical Advisory Group for Infectious Hazards; expert in Viral Hemorrhagic Fever[1]
- WHO Ad hoc advisor to the Strategic Advisory Group of Exports on Immunization (SAGE) committee[1]
- WHO High Priority Pathogens committee[1]
- Advisor to the WHO Deputy Director-General, Emergency Preparedness and Response[1]
References
- ^ a b c d e f g h i j k l m n o p q "Dr. Gary Kobinger to join GNL as new Director". Galveston National Laboratory. Retrieved 8 March 2022.
- ^ a b c d e f "Gary Kobinger". Universities Canada. Retrieved 8 March 2022.
- ^ S2CID 38910813.
- ^ "ZMapp treats patients with the Ebola virus". Governor General’s Innovation Awards. Retrieved 8 March 2022.
- ^ a b c d e f g h i j Branswell, Helen (7 January 2020). "'Against all odds': The inside story of how scientists across three continents produced an Ebola vaccine". STAT. Retrieved 8 March 2022.
- ^ a b Carpentier, Camille (June 18, 2021). "L'éminent chercheur Gary Kobinger poursuivra ses recherches au Texas". Radio-Canada.ca (in Canadian French). Retrieved 8 March 2022.
- ^ Larin, Vincent (June 17, 2021). "A prominent Quebec researcher leaves for Texas – The Canadian News". The Canadian News. Retrieved 8 March 2022.
- ^ New experts appointed to join CEPI Scientific Advisory Committee Coalition for Epidemic Preparedness Innovations (CEPI), press release of 6 November 2023.
- ^ a b c "Gary Kobinger". Cercle des Ambassadeurs de Québec. Retrieved 8 March 2022.
External links
- Gary Kobinger at University of Texas Medical Branch
- GuardRX(Founder and CEO)
- Gary Kobinger Profile
- Gary Kobinger at ResearchGate